Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

150
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
150
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

593
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
593
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

702
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
702
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

295
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
295
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

192
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
192
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

172
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
172

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Simple Risk Assessment Tool for Older Adult Trauma Patients-Silver Trauma Score.

The Journal of surgical research·2026
Same author

Optimizing the timing of autologous skin cell suspension after enzymatic debridement of porcine burns: Evaluation with digital image speckle correlation.

JID innovations : skin science from molecules to population health·2026
Same author

"Probably a Little Bit of a Hill to Climb": A qualitative study of emergency department providers' perceptions of nonpharmacological pain treatment.

PloS one·2026
Same author

Smartphone Keystroke Biomarkers as Predictors of Adverse Neuropsychiatric Sequelae After Trauma in Trauma Survivors: Prospective Observational Cohort Study.

Journal of medical Internet research·2026
Same author

Associations between residential segregation, ambient air pollution, and hippocampal features in recent trauma survivors.

Translational psychiatry·2026
Same author

Terahertz spectral imaging for early assessment of frostbite injuries using the double Debye model and supervised machine learning.

Biomedical optics express·2026

Related Experiment Video

Updated: Dec 25, 2025

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.6K

Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency

W Frank Peacock1, Robert Christenson2, Deborah B Diercks3

  • 1From the, Emergency Medicine, Baylor College of Medicine, Houston, TX.

Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|March 29, 2020
PubMed
Summary

High-sensitivity troponin I assays can accurately rule out acute myocardial infarction (AMI) within 3 hours in emergency department patients. Utilizing level-of-quantification cutpoints ensures a 100% negative predictive value for AMI, improving patient care.

More Related Videos

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
11:17

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

Published on: November 28, 2025

104
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.6K

Related Experiment Videos

Last Updated: Dec 25, 2025

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.6K
A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
11:17

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

Published on: November 28, 2025

104
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.6K

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Clinical Chemistry

Background:

  • Accurate and rapid exclusion of acute myocardial infarction (AMI) is crucial for emergency department (ED) efficiency and resource management.
  • High-sensitivity troponin I (hsTnI) assays are used to rule in AMI, but their ability to rule out AMI requires further evaluation.
  • The Beckman Coulter hsTnI assay's performance using various level-of-quantification (LoQ) cutpoints for ruling out AMI within 3 hours needs assessment in suspected acute coronary syndrome (ACS) patients.

Purpose of the Study:

  • To evaluate the Beckman Coulter hsTnI assay's ability to rule out AMI within 3 hours of ED presentation.
  • To assess the utility of various LoQ cutpoints in conjunction with the upper reference level (URL) for AMI exclusion.
  • To determine the negative predictive value (NPV) and sensitivity of the hsTnI assay for ruling out AMI.

Main Methods:

  • A multicenter study enrolled adults with ACS symptoms, excluding those with ST-elevation MI or on chronic hemodialysis.
  • Blood samples were collected at baseline and at 1-3, 3-6, and 6-9 hours postadmission; hsTnI levels were tested at three independent labs.
  • Analytical cutpoints included the URL (17.9 ng/L) and two LoQ cutpoints (5.6 ng/L at 10% CV, 2.3 ng/L at 20% CV); AMI diagnosis was adjudicated by an independent committee.

Main Results:

  • Of 1,049 patients, 11.2% had an adjudicated AMI diagnosis. Patients with any hsTnI result below the 20% LoQ (n=231) had a 100% NPV for AMI.
  • Patients with any hsTnI below the 10% LoQ (n=611) also demonstrated a 100% NPV for AMI.
  • In the 'Hi-Hi' cohort (both hsTnI > LoQ, but < URL), the NPV was 98.2% and sensitivity was 96.6% for AMI.

Conclusions:

  • Patients presenting >3 hours after symptom onset with two hsTnI values < URL, with at least one below the 10% or 20% LoQ, had a 100% NPV for AMI.
  • Two hsTnI values within 1-3 hours, both < URL but > LoQ, showed inadequate sensitivity and NPV for AMI exclusion.
  • The Beckman Coulter hsTnI assay, using specific LoQ cutpoints, can effectively rule out AMI within 3 hours in suspected ACS patients.